Baird Financial »

Adma Biologics shares owned by Baird Financial

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Baird Financial from 13F filings

Historical chart of Baird Financial investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Baird Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Baird Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 100k 14.66
2025-06-30 $2.1M 115k 18.21

More positions owned by Baird Financial

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Jpmorgan Chase Common (JPM)
Alphabet Inc C Common (GOOG)
Ishares Tr Rus 1000 Grw Etf Common (IWF)
Berkshire Hathaway Inc Del Cl Common (BRK.B)
Meta Platforms Inc A Common (META)
Ishares Tr Rus 1000 Val Etf Common (IWD)
Home Depot Common (HD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt Common (VEA)
Ge Aerospace Common (GE)
Ge Vernova Common (GEV)
Progressive Corp Common (PGR)
Amazon Common (AMZN)
Nvidia Corp Common (NVDA)

View all positions for Baird Financial

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Geode Capital Management
Nuveen
Westfield Capital Management Company
Dimensional Fund Advisors
American Century Companies
Thrivent Financial for Lutherans
Citadel Advisors
Capital Research Global Investors
Goldman Sachs Group
Franklin Resources

View all funds holding Adma Biologics